CA Stock MarketDetailed Quotes

PHRX Pharmadrug Inc

Watchlist
  • 0.015
  • -0.005-25.00%
15min DelayMarket Closed Nov 15 15:36 ET
1.60MMarket Cap-65P/E (TTM)

Pharmadrug Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-57.49%-204.77K
-489.36%-543.75K
65.51%-671.88K
-100.50%-15.97K
93.90%-200.86K
73.45%-130.02K
91.03%-92.26K
34.43%-1.95M
644.77%3.17M
-403.12%-3.29M
Net income from continuing operations
65.71%-144.02K
-202.70%-541.15K
-332.83%-13.26M
-625.81%-12.36M
89.70%-300.01K
52.77%-419.98K
88.93%-178.77K
28.48%-3.06M
301.05%2.35M
-203.45%-2.91M
Operating gains losses
----
----
129.72%160.65K
-194.35%-16.57K
108.80%49.11K
--71.76K
--56.35K
40.14%-540.59K
--17.56K
---558.15K
Depreciation and amortization
--12.56K
--12.56K
24.67%26.22K
407.66%26.22K
--0
--0
--0
31.28%21.03K
-553.49%-8.52K
2.04%5.71K
Asset impairment expenditure
----
----
--11.12M
----
----
----
----
--0
----
----
Unrealized gains and losses of investment securities
--0
--0
-120.67%-122.27K
-92.81%16.39K
-82.62%23.15K
-103.34%-2.96K
-212.20%-158.84K
-63.51%591.47K
-44.80%227.99K
-28.27%133.2K
Remuneration paid in stock
--47.23K
----
404.92%1.74M
--1.74M
--0
--0
----
-42.52%344.76K
--0
-98.04%2.22K
Deferred tax
----
----
-431.76%-1.01M
----
----
----
----
---190K
----
----
Other non cashItems
-8.69%82.16K
5.77%92.46K
89.90%384.33K
110.55%180.05K
-23.60%26.89K
119.39%89.97K
155.22%87.42K
79.26%202.39K
800.51%85.51K
4.15%35.2K
Change In working capital
-254.52%-202.7K
-205.95%-107.63K
-57.21%294.04K
----
----
-47.47%131.18K
52.78%101.58K
615.98%687.22K
----
----
-Change in receivables
225.38%4.84K
-441.78%-46.67K
106.66%3.78K
----
----
97.14%-3.86K
260.43%13.65K
-193.84%-56.68K
----
----
-Change in inventory
----
----
--0
----
----
----
----
2,808.36%73.41K
----
----
-Change in prepaid assets
-1,196.49%-50K
--0
-70.25%8.68K
----
----
-92.58%4.56K
115.57%4.56K
243.68%29.17K
----
----
-Change in payables and accrued expense
-220.74%-157.54K
-173.12%-60.96K
-38.46%351.58K
----
----
-53.75%130.49K
-18.35%83.37K
424.96%571.32K
----
----
-Change in other working capital
----
----
-200.00%-70K
----
----
----
----
--70K
----
----
Cash from discontinued investing activities
0
73.28%-309.34K
Operating cash flow
-57.49%-204.77K
-489.36%-543.75K
70.23%-671.88K
-100.56%-15.97K
93.90%-200.86K
78.99%-130.02K
92.63%-92.26K
45.33%-2.26M
352.57%2.86M
-285.12%-3.29M
Investing cash flow
Cash flow from continuing investing activities
0
0
1,114.75%995.04K
686.69%741.24K
131.76%8.04K
37.83K
207.92K
-94.62%81.91K
153.08%94.22K
104.04%3.47K
Net business purchase and sale
----
----
6,197.21%741.54K
500,942.57%741.54K
--0
----
----
-103.93%-12.16K
14,900.00%148
106.56%3.47K
Net investment purchase and sale
--0
--0
169.46%253.5K
-100.32%-300
--8.04K
--37.83K
--207.92K
-92.25%94.08K
9,407,400.00%94.08K
--0
Cash from discontinued investing activities
0
0
0
89.85%-4.34K
0
0
Investing cash flow
--0
--0
1,182.65%995.04K
686.69%741.24K
131.76%8.04K
1,472.29%37.83K
13,267.95%207.92K
-94.76%77.58K
2,056.46%94.22K
104.00%3.47K
Financing cash flow
Cash flow from continuing financing activities
0
379.73%326K
-74.40%225.51K
-75.86%93.15K
-3,546.43%-116.54K
4.74%880.87K
Net issuance payments of debt
--0
--0
-99.34%4K
----
----
6,566.67%100K
-2,903.75%-96K
--601.8K
----
----
Net common stock issuance
--0
--326K
--0
----
----
--0
--0
--280K
----
----
Cash dividends paid
--0
--0
--0
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
----
----
--0
----
----
----
----
-88.89%106K
----
----
Interest paid (cash flow from financing activities)
--0
--0
-100.19%-78.49K
----
----
---6.85K
---20.54K
65.29%-39.21K
----
----
Net other financing activities
----
----
542.97%300K
----
----
----
----
---67.72K
----
----
Cash from discontinued financing activities
0
41.24%-37.63K
Financing cash flow
--0
379.73%326K
-73.26%225.51K
----
----
-74.18%93.15K
-612.26%-116.54K
8.53%843.25K
----
----
Net cash flow
Beginning cash position
3,994.93%342.38K
6,447.39%560.13K
-99.12%8.41K
474.15%160.1K
-48.54%9.92K
-89.18%8.36K
-99.11%8.56K
-55.13%957.98K
-98.40%27.88K
-99.34%19.28K
Current changes in cash
-21,408.01%-204.77K
-24,644.55%-217.75K
141.06%548.67K
1,157.09%399.41K
-39.99%149.18K
100.37%961
99.93%-880
28.57%-1.34M
96.72%-37.78K
123.24%248.61K
Effect of exchange rate changes
--0
--0
-99.21%3.05K
-95.81%773
100.41%993
-99.73%601
-99.82%686
-44.25%386.91K
-94.91%18.46K
-190.64%-240.01K
Cash adjustments other than cash changes
----
----
----
----
--0
----
----
----
----
--0
End cash Position
1,286.75%137.61K
3,994.93%342.38K
6,447.39%560.13K
6,447.39%560.13K
474.15%160.1K
-48.54%9.92K
-89.18%8.36K
-99.11%8.56K
-99.11%8.56K
-98.40%27.88K
Free cash from
-57.49%-204.77K
-489.36%-543.75K
70.23%-671.88K
-100.56%-15.97K
93.90%-200.86K
78.99%-130.02K
92.63%-92.26K
45.33%-2.26M
361.15%2.86M
-270.77%-3.29M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -57.49%-204.77K-489.36%-543.75K65.51%-671.88K-100.50%-15.97K93.90%-200.86K73.45%-130.02K91.03%-92.26K34.43%-1.95M644.77%3.17M-403.12%-3.29M
Net income from continuing operations 65.71%-144.02K-202.70%-541.15K-332.83%-13.26M-625.81%-12.36M89.70%-300.01K52.77%-419.98K88.93%-178.77K28.48%-3.06M301.05%2.35M-203.45%-2.91M
Operating gains losses --------129.72%160.65K-194.35%-16.57K108.80%49.11K--71.76K--56.35K40.14%-540.59K--17.56K---558.15K
Depreciation and amortization --12.56K--12.56K24.67%26.22K407.66%26.22K--0--0--031.28%21.03K-553.49%-8.52K2.04%5.71K
Asset impairment expenditure ----------11.12M------------------0--------
Unrealized gains and losses of investment securities --0--0-120.67%-122.27K-92.81%16.39K-82.62%23.15K-103.34%-2.96K-212.20%-158.84K-63.51%591.47K-44.80%227.99K-28.27%133.2K
Remuneration paid in stock --47.23K----404.92%1.74M--1.74M--0--0-----42.52%344.76K--0-98.04%2.22K
Deferred tax ---------431.76%-1.01M-------------------190K--------
Other non cashItems -8.69%82.16K5.77%92.46K89.90%384.33K110.55%180.05K-23.60%26.89K119.39%89.97K155.22%87.42K79.26%202.39K800.51%85.51K4.15%35.2K
Change In working capital -254.52%-202.7K-205.95%-107.63K-57.21%294.04K---------47.47%131.18K52.78%101.58K615.98%687.22K--------
-Change in receivables 225.38%4.84K-441.78%-46.67K106.66%3.78K--------97.14%-3.86K260.43%13.65K-193.84%-56.68K--------
-Change in inventory ----------0----------------2,808.36%73.41K--------
-Change in prepaid assets -1,196.49%-50K--0-70.25%8.68K---------92.58%4.56K115.57%4.56K243.68%29.17K--------
-Change in payables and accrued expense -220.74%-157.54K-173.12%-60.96K-38.46%351.58K---------53.75%130.49K-18.35%83.37K424.96%571.32K--------
-Change in other working capital ---------200.00%-70K------------------70K--------
Cash from discontinued investing activities 073.28%-309.34K
Operating cash flow -57.49%-204.77K-489.36%-543.75K70.23%-671.88K-100.56%-15.97K93.90%-200.86K78.99%-130.02K92.63%-92.26K45.33%-2.26M352.57%2.86M-285.12%-3.29M
Investing cash flow
Cash flow from continuing investing activities 001,114.75%995.04K686.69%741.24K131.76%8.04K37.83K207.92K-94.62%81.91K153.08%94.22K104.04%3.47K
Net business purchase and sale --------6,197.21%741.54K500,942.57%741.54K--0---------103.93%-12.16K14,900.00%148106.56%3.47K
Net investment purchase and sale --0--0169.46%253.5K-100.32%-300--8.04K--37.83K--207.92K-92.25%94.08K9,407,400.00%94.08K--0
Cash from discontinued investing activities 00089.85%-4.34K00
Investing cash flow --0--01,182.65%995.04K686.69%741.24K131.76%8.04K1,472.29%37.83K13,267.95%207.92K-94.76%77.58K2,056.46%94.22K104.00%3.47K
Financing cash flow
Cash flow from continuing financing activities 0379.73%326K-74.40%225.51K-75.86%93.15K-3,546.43%-116.54K4.74%880.87K
Net issuance payments of debt --0--0-99.34%4K--------6,566.67%100K-2,903.75%-96K--601.8K--------
Net common stock issuance --0--326K--0----------0--0--280K--------
Cash dividends paid --0--0--0----------0--0--0--------
Proceeds from stock option exercised by employees ----------0-----------------88.89%106K--------
Interest paid (cash flow from financing activities) --0--0-100.19%-78.49K-----------6.85K---20.54K65.29%-39.21K--------
Net other financing activities --------542.97%300K-------------------67.72K--------
Cash from discontinued financing activities 041.24%-37.63K
Financing cash flow --0379.73%326K-73.26%225.51K---------74.18%93.15K-612.26%-116.54K8.53%843.25K--------
Net cash flow
Beginning cash position 3,994.93%342.38K6,447.39%560.13K-99.12%8.41K474.15%160.1K-48.54%9.92K-89.18%8.36K-99.11%8.56K-55.13%957.98K-98.40%27.88K-99.34%19.28K
Current changes in cash -21,408.01%-204.77K-24,644.55%-217.75K141.06%548.67K1,157.09%399.41K-39.99%149.18K100.37%96199.93%-88028.57%-1.34M96.72%-37.78K123.24%248.61K
Effect of exchange rate changes --0--0-99.21%3.05K-95.81%773100.41%993-99.73%601-99.82%686-44.25%386.91K-94.91%18.46K-190.64%-240.01K
Cash adjustments other than cash changes ------------------0------------------0
End cash Position 1,286.75%137.61K3,994.93%342.38K6,447.39%560.13K6,447.39%560.13K474.15%160.1K-48.54%9.92K-89.18%8.36K-99.11%8.56K-99.11%8.56K-98.40%27.88K
Free cash from -57.49%-204.77K-489.36%-543.75K70.23%-671.88K-100.56%-15.97K93.90%-200.86K78.99%-130.02K92.63%-92.26K45.33%-2.26M361.15%2.86M-270.77%-3.29M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data